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In the UK the past 5 years has seen the real emergence of an open, honest culture in healthcare and medical practice which 
recognizes that healthcare can cause harm to patients. This year has seen the launch of the National Patient Safety 
campaign which builds on the NHS Adverse Drug Event Collaborative and the Institute of Health Improvement Safer 
Patients Initiative.[1] The Patient Safety First campaign is being developed in response to the worldwide issue of improving 
patient safety and is supported by the NHS Institute for Innovation and Improvement, the National Patient Safety Agency 
(NPSA) and The Health Foundation.[2–4] 
The Patient Safety First Campaign for England, by the service, for the service, states its cause as ‘To make the safety of 
patients everyone’s highest priority’, and its aim as ‘No avoidable death and no avoidable harm’. Pharmacists must be 
linked to this initiative through their organization’s participation and currently the campaign is focused on 
secondary care. The campaign has focused on five key workstreams,[5] as follows. Leadership for safety: getting Boards on 
board with patient safety, with the aim of demonstrating that it is the highest priority. The goal is to ensure a leadership 
culture at Board level which promotes quality and patient safety and provides an environment where continuous 
improvement in harm reduction becomes routine throughout the organization. Care of deteriorating patients in acute care: 
the goal is to reduce in-hospital cardiac arrest and mortality rates through earlier recognition and treatment of the 
deteriorating patient. 
Critical care bundles (central lines, ventilator care): with the goal of improving the care of patients receiving critical care 
through the reliable application of care bundles. Perioperative care: including prevention of surgical-site infection and the 
World Health Organization’s Safe Surgery Checklist. The goal is to improve care for adult patients undergoing elective 
surgical procedures in the hospital setting. 
Reduction of harm from high-risk medications: this includes anticoagulants, narcotics, insulin and sedatives. The goal of 
this workstream is to prevent harm from high-risk medications. 
Health professions and services must put patient safety as their number one priority and managers must strive to enable 
practitioners to keep their patients safe. Pharmacists work within the framework of ensuring that their patients receive safe 
and effective drug therapy but perhaps only more recently has the service been able to provide this level of practice 
uniformly. Pharmaceutical departments need to embrace the core principle that patient safety is our number one priority. 
We must fundamentally question the way in which we organize, manage and deliver our services and question our 
priorities, as surely it is inappropriate to put our staff in situations of clinical practice where they do not feel safe 
and cannot ensure the safety of their patients. There are a number of basic factors which need to be examined by 
pharmaceutical services. 
(1) Leadership: do we organize our services to support patient safety? (2) Embedding principles of safe and effective 
prescribing: have we utilized the breadth of research on effective prescribing, medication errors, medicines reconciliation 
and discharge planning, and have we implemented these practices? (3) Measurement of clinical interventions: do we use 
effectively data that we have identified; for example, pharmacy interventions, medicines reconciliation and discharge 
issues? (4) Implementing change in practice: are all Trusts able to secure appropriate numbers of pharmacists and 
technicians to ensure that we can implement throughout the organization adequate pharmaceutical support to ensure 
patient safety? (5) Education and training of pharmacists: undergraduate and postgraduate pharmacy 
programmes need to demonstrate clear learning outcomes to enhance the pharmacist’s understanding of human factors, 
techniques to minimize adverse drug events and safe and effective prescribing practices. 
In the US some of the leading hospitals have harnessed a transformational approach to patient safety. For example, theUS 
Ascension Health System aims to achieve ‘no preventable injuries or deaths in 5 years by end of 2008’.[6] Ascension’s 
approach is a combination of their determination to meet the external regulatory goals, their absolute focus on developing 
a culture of safety and workstreams which aim to motivate staff to examine and improve their practice. Pharmaceutical 
services need to embrace this approach. 
Pharmacy is a unique discipline with a culture of patient safety, but we have weakness in executing and embedding 
our role in practice. From drug design to development –that is, in terms of a drug molecule arriving in clinical 
practice – we have robust regulatory frameworks. We do, however, recognize that we must examine continuously the 
risks at each stage of the drug-development process in the light of adverse events seen with new biotechnology 
products at the stage of clinical trials. The availability of and access to medications from abroad requires pharmacists 
to educate patients to ensure that they understand the regulatory frameworks around products available in Europe 
and the UK and the potential risks if medicines are purchased in countries where the frameworks may not be as 
rigorous. 
Pharmacists are the key health professionals providing pharmaceutical care services. The evidence base is now 
strong and we can identify some 500 000–600 000 patients  per year admitted to NHS hospitals in England and Wales 
who may experience a patient safety incident; some untoward events and medication errors are serious enough 
to contribute to unexpected mortality.[7] Medication errors are broadly defined as any error in the 
prescribing, dispensing or administration of a drug, irrespective of whether such errors lead to adverse 
consequences or not. They are a growing problem in the UK, although estimates can differ due to the variety of 
criteria and definitions used: hospital incidence of medication errors may range from 4.4 to 6.2 events per 100 
admissions. The NPSA has identified that certain key drug classes – antibiotics, painkillers and sedatives – are likely to 
be the most common types associated with medication error. The National Patient Safety campaign has identified 
anticoagulants, narcotics, insulin and sedatives as high-risk medicines, with intravenous drug administration being a 
particular target. 
How strong and robust are our reporting systems? The evidence is clear that we are underestimating the extent of 
the problem. Medication errors are the single most preventable cause of patient harm. The landmark Institute 
of Medicine report, To Err is Human: Building a Safer Health System,[8,9] estimated that errors in medical management 
lead to between 44 000 and 98 000 deaths in the US each year, although these figures have been questioned. 
Incident rates of medication errors vary widely, the reason for which can be explained by the different study methods 
and definitions used. The rate of medication errors varies between 2 and 14% of patients admitted to hospital, 
with 1–2% of patients in the US being harmed as a result, and the majority are due to poor prescribing. Medication 
error has been estimated to kill 7000 patients per annum and accounts for nearly one in 20 hospital admissions in the 
US. The incidence is similar in the UK. Medication errors (7% of all incidents) were the second most common 
incident reported (after patient falls) in a recent National Audit Office report[10] on patient safety. Pharmacy services 
need a comprehensive and effective way to identify events that do cause harm to patients. Perhaps we should be fully 
integrating the Institute of Health Improvement Global Trigger Tool, which is intended to be used to identify all 
categories of adverse events including those related to medications.[11] 
The history of the development of clinical pharmacy, pharmaceutical care and medicines management put the 
pharmacist in a unique position to play a lead role in patient safety by ensuring medication safety for patients. 
Fundamental to our role is ensuring we have rational and effective guidelines and formulary management systems. What is 
sad is that work in the late 1980s and early 1990s recognized the importance of formulary management of antibiotic 
prescribing, yet it is only over the past few years that organizations have embedded antibiotic prescribing policies to 
manage the risks of MRSA and Clostridium difficile. 
Pharmacists need to ensure that patients can manage their medicines effectively though their role in the drug-use 
process. Practice research has now provided an evidence base which shows how electronic prescribing. medicines 
reconciliation and pharmaceutical care in discharge planning can ensure the effectiveness and safety of medicines 
use. However, in 2008 we are only now starting to develop the IT infrastructure for electronic prescribing and discharge, 
we have not embedded effective pharmaceutical care in discharge-management processes, and still patients 
do not take their medicines appropriately and have significant medication-related problems. Pharmacy developments 
must now implement more effectively our service principles and goals of delivering pharmaceutical care to 
ensure that patients are safe and to achieve effective health outcomes. 
Pharmacists must not take 20 years to embrace patient safety tools. Managers must play a crucial leadership role in 
creating a culture of patient safety which transforms the delivery of effective pharmaceutical services, putting patient 
safety as the number one priority.  
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